1449.47GBp+1.93%Mkt Cap: 3.11B GBpP/E: 10.70Last update: 2026-05-18
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. Th…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Company
Market Cap3.11B GBp
Enterprise Value4.54B GBp
Revenue (TTM)3.35B GBp
Gross Profit1.44B GBp
Net Income (TTM)402.00M GBp
Revenue/Share15.18 GBp
Last Price1449.47 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees9.4K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINGB00B0LCW083
Valuation
P/E (Trailing)10.70
P/E (Forward)7.76
PEG1.71
EV/EBITDA5.40
EV/Revenue1.36
P/S0.92
P/B1.65
EPS (TTM)1.34
EPS (Forward)1.86
52W Range
1187.0027% of range2164.00
52W High2164.00 GBp
52W Low1187.00 GBp
Profitability
Gross Margin43.03%
Oper. Margin16.20%
EBITDA Margin25.14%
Profit Margin12.00%
ROE15.50%
ROA7.09%
Growth
Revenue Growth8.50%
Earnings Growth23.50%
Cash Flow & Leverage
Operating CF436.00M GBp
CapEx (TTM)317.00M GBp
FCF Margin-1.97%
FCF Yield-2.13%
Net Debt1.36B GBp
Net Debt/EBITDA1.62
Balance Sheet
Debt/Equity0.62
Current Ratio1.82
Quick Ratio0.91
Book Value/Sh8.710 GBp
Cash/Share1.104 GBp
Dividends
Fwd Div Rate0.6200 GBp
Trail. Div Rate0.8400 GBp
Div. Yield4.29%
5Y Avg Yield2.77%
Payout Ratio46.49%
Ex-Div DateMar 19, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)1915.69 GBp
Target Range1363.64 GBp – 2660.77 GBp
# Analysts11
Ownership
Shares Out.214.37M
Float151.33M
Insiders31.70%
Institutions45.88%
Technical
SMA 501326.66 (+9.3%)
SMA 2001554.27 (-6.7%)
Beta0.64
S&P 52W Chg24.23%
Avg Vol (30d)914.79K
Avg Vol (10d)703.31K
Technical Indicators
RSI (14)64.6
MACD26.2769
MACD Signal22.9252
MACD Hist.+3.3517
BB Upper1454.55 GBp
BB Middle1391.00 GBp
BB Lower1327.44 GBp
BB Width9.14%
ATR (14)39.09 GBp
Vol Ratio (20d)1.48x